FT
MEDP icon

Fiduciary Trust’s Medpace MEDP Stock Holding History

Fiduciary Trust’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816K Sell
1,541
-163
-10% -$75.2K 0.01% 463
2026
Q1 		$818K Hold
1,704
– – 0.01% 452
2025
Q4 		$957K Sell
1,704
-494
-22% -$280K 0.01% 421
2025
Q3 		$1.13M Sell
2,198
-195
-8% -$85.1K 0.01% 394
2025
Q2 		$751K Buy
2,393
+326
+16% +$97.9K 0.01% 459
2025
Q1 		$630K Buy
2,067
+1,420
+219% +$478K 0.01% 483
2024
Q4 		$215K Buy
+647
New +$219K ﹤0.01% 646

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fiduciary Trust's MEDP Position: Q2 2026 in Review

Fiduciary Trust reduced its Medpace (MEDP) stake by 9.6% in Q2 2026, selling an estimated $75.2K and leaving 1,541 shares worth $816K. The position accounts for 0.01% of the portfolio, ranked #463.

Fiduciary Trust first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Fiduciary Trust held 1,541 shares of Medpace worth $816K as of Q2 2026.
  • Fiduciary Trust sold 163 Medpace shares in Q2 2026, an estimated $75.2K.
  • Medpace made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #463 holding.
  • Fiduciary Trust first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Fiduciary Trust's Medpace position peaked at $1.13M in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.